DBPR-114 CAS:2443767-35-7
DBPR-114
						| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product | 
|---|---|---|---|---|
| R-C-1608 | 200mg | 820.00 | + Add to cart  | 
																					|
| R-C-1608 | 500mg | 1520.00 | + Add to cart  | 
																					|
| R-C-1608 | 1g | 2450.00 | + Add to cart  | 
																					|
| 
										 | 
								||||
Product description
							BPR1K871 is a potent and selective dual FLT3/AURKA inhibitor with IC50s of 19 nM and 22 nM for FLT3 and AURKA,respectively,acts as a preclinical development candidate for anti-cancer therapy.
| Appearance | N/A | 
|---|---|
| Molecular Weight | N/A | 
| purity | >95% | 
| PDI by GPC | <1.5 | 
| Solubility | N/A | 
| Storage | -20℃, protected from light and moisture | 
| Transportation | 4-25℃ temperature for up to 2 weeks | 
| Stability | 1 year | 
Document
							Related Product
							
						
Items-$0.00

Email:
Tel.:
msds---DBPR-114 
                    RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
                
                    Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China 
                
                    Tel:  02988811435
                
                    Fax: (86-29)8881-1435
                
                    Email: sales@ruixibiotech.com
                
                    Web: http://www.ruixibiotech.com    
					
							
                

